Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiaan Engelborghs

Showing results (281-290 of 359) with videos related to

Pageof 36
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2017
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairmentSanna-Kaisa Herukka, Anja Hviid Simonsen, Niels Andreasen, et al.
Alzheimer'S Research & Therapy|June 16, 2025
Independent validation and outlier analysis of EuroPOND alzheimer's disease staging model using ADNI and real-world clinical dataMandy M J Wittens, Diana M Sima, Arne Brys, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
Journal of Alzheimer'S Disease : JAD|August 2, 2021
Diagnostic Performance of Automated MRI Volumetry by icobrain dm for Alzheimer's Disease in a Clinical Setting: A REMEMBER StudyMandy Melissa Jane Wittens, Diana Maria Sima, Ruben Houbrechts, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 6, 2024
CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's diseaseAurore Delvenne, Johan Gobom, Suzanne E Schindler, et al.
Acta Neuropathologica|March 31, 2016
A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer's diseaseJan Verheijen, Tobi Van den Bossche, Julie van der Zee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 12, 2019
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrumIsabelle Bos, Stephanie Vos, Frans Verhey, et al.
Fluids and Barriers of the CNS|July 17, 2024
Involvement of the choroid plexus in Alzheimer's disease pathophysiology: findings from mouse and human proteomic studiesAurore Delvenne, Charysse Vandendriessche, Johan Gobom, et al.
Neurobiology of Aging|November 18, 2017
Common and rare TBK1 variants in early-onset Alzheimer disease in a European cohortJan Verheijen, Julie van der Zee, Ilse Gijselinck, et al.
Molecular Neurodegeneration|March 29, 2022
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
Pageof 36

Showing results (281-290 of 359) with videos related to

Sort By:
Pageof 36
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2017
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairmentSanna-Kaisa Herukka, Anja Hviid Simonsen, Niels Andreasen, et al.
Alzheimer'S Research & Therapy|June 16, 2025
Independent validation and outlier analysis of EuroPOND alzheimer's disease staging model using ADNI and real-world clinical dataMandy M J Wittens, Diana M Sima, Arne Brys, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
Journal of Alzheimer'S Disease : JAD|August 2, 2021
Diagnostic Performance of Automated MRI Volumetry by icobrain dm for Alzheimer's Disease in a Clinical Setting: A REMEMBER StudyMandy Melissa Jane Wittens, Diana Maria Sima, Ruben Houbrechts, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 6, 2024
CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's diseaseAurore Delvenne, Johan Gobom, Suzanne E Schindler, et al.
Acta Neuropathologica|March 31, 2016
A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer's diseaseJan Verheijen, Tobi Van den Bossche, Julie van der Zee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 12, 2019
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrumIsabelle Bos, Stephanie Vos, Frans Verhey, et al.
Fluids and Barriers of the CNS|July 17, 2024
Involvement of the choroid plexus in Alzheimer's disease pathophysiology: findings from mouse and human proteomic studiesAurore Delvenne, Charysse Vandendriessche, Johan Gobom, et al.
Neurobiology of Aging|November 18, 2017
Common and rare TBK1 variants in early-onset Alzheimer disease in a European cohortJan Verheijen, Julie van der Zee, Ilse Gijselinck, et al.
Molecular Neurodegeneration|March 29, 2022
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
Pageof 36